Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 42.10
-0.90 (-2.09%)
Jun 4, 2026, 1:25 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 192.57 million as of June 4, 2026.
Market Cap
192.57M
Enterprise Value
18.52M
Revenue
28.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.10
Market Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 192.57M, an increase of 3.31%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 192.57M | -12.42% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.00B |
| Thor Medical ASA | 1.57B |
| Nykode Therapeutics AS | 1.07B |
| ArcticZymes Technologies ASA | 1.05B |
| Lytix Biopharma ASA | 761.31M |
| Zelluna ASA | 567.43M |
| SoftOx Solutions AS | 291.32M |
| Arctic Bioscience AS | 85.72M |